Cancer
COVID-19 and Cancer: D-H Doctors Discuss Vaccine Safety for Cancer Patients on “The Cure Podcast”
Special guest, DHMC Interim Section Chief of Medical Oncology Gary N. Schwartz, MD.
Gifts Totaling $3.35 Million will Fuel Cancer Research in New Hampshire
A Dartmouth faculty member, a husband grateful for the care his wife received, and a Dartmouth College alumna and her husband have made gifts to accelerate immunotherapy research at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center.
Piloting a FLASH Radiotherapy Beam for Treatment of Cancer
Researchers convert a standard linear accelerator used for radiation therapy, to deliver an ultra-high-dose rate beam to cancer patients “in a flash.”
Cancer Doesn’t Stop for COVID-19: Dartmouth-Hitchcock’s Norris Cotton Cancer Center Joins Nationwide Effort to Resume Cancer Screening
“Cancer did not pause for COVID-19 and neither did we,” says NCCC director Steven D. Leach, MD
Cancer Care Close to Home: New Hampshire’s Only NCI-Designated Comprehensive Cancer Center Expands Cancer Services in Southern New Hampshire
Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center will open two new specialty clinics, NeuroOncology and Gynecologic Oncology, at their Dartmouth-Hitchcock location at the Catholic Medical Center’s Notre Dame Pavilion in Manchester.
Lionel D. Lewis, MD, Elected as a 2020 Fellow of the British Pharmacological Society
Dr. Lewis elected for prestigious fellowship for his substantial contributions, demonstrated distinction, and peer recognition in clinical pharmacology and therapeutics.
Researchers Find Source of Breast Tumor Heterogeneity and Pathway that Limits Emergence
Researchers find a signaling pathway that limits mammary basal cells’ ability to fuel the growth of multiple aggressive cell populations within a breast tumor, uncovering opportunities for novel therapeutic approaches to breast cancer.
Norris Cotton Cancer Center Launches New Cellular Therapy Program
NCCC treats the first patients with new CAR T-cell therapy.
Kim Levitch and the Supercharged, Cancer-Killing CAR T-Cells
Kim Levitch becomes the first patient at Norris Cotton Cancer Center to undergo the newest cancer immunotherapy, CAR T-cell therapy.